Delivery Order SPE2DB24D1205-SPE2DB25FCZMG
- Not listed
- The Defense Logistics Agency awarded a $4,457.88 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 4, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,915.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract, executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) for Zilretta 32 mg vials valued at $8,915.76 under a firm fixed-price contract structure. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a non-set-aside competitive procurement, with performance to be completed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,287.25 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Zilretta 32 mg vials. The competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and involves performance at the vendor's Conshohocken facility. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a $3,714.90 delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed price, non-set-aside contract awarded on July 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, indicating this procurement supports military healthcare needs for pain...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,041,099 units of the pharmaceutical product ZILRETTA 32 MG VIALS. The $3,505.70 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corporation is the prime contractor for this award, which is not associated with any set-aside designations. Additionally,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.94 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZMGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, valued at $1,485.96 with a firm fixed price structure. The contract, awarded on August 13, 2025, carries an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The competitively awarded contract reflects the company's established capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/13/25 |